Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

MMYRIAD GENETICS INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
M

MYRIAD GENETICS INC

$4.02Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $190.7M. Net result −$43.2M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $190.7M. Running result $190.7M. Cancer Care Continuum: $114.1M. Mental Health: $36.8M. Prenatal Health: $39.8M.
  • Cost of revenue: −$63.7M. Running result $127M.
  • Gross profit: $127M. Running result $127M.
  • Research and development expense: −$25M. Running result $102M.
  • Sales and marketing expense: −$83.1M. Running result $18.9M.
  • General and administrative expense: −$57.8M. Running result −$38.9M.
  • Goodwill and long-lived asset impairment charges: $0. Running result −$38.9M.
  • Operating income: −$38.9M. Running result −$38.9M.
  • Other expense: −$3.7M. Running result −$42.6M.
  • Pre-tax loss: −$42.6M. Running result −$42.6M.
  • Income tax expense: −$600K. Running result −$43.2M.
  • Net loss: −$43.2M. Running result −$43.2M.